PROGENTOS THERAPEUTICS Trademark
Trademark Overview
On Wednesday, February 14, 2024, a trademark application was filed for PROGENTOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROGENTOS THERAPEUTICS trademark a serial number of 98404794. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 28, 2024. This trademark is owned by Progentos Therapeutics, Inc.. The PROGENTOS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders
Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders
General Information
| Serial Number | 98404794 |
| Word Mark | PROGENTOS THERAPEUTICS |
| Filing Date | Wednesday, February 14, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, October 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 7, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders |
| NOT AVAILABLE | THERAPEUTICS |
| Goods and Services | Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 14, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 14, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Progentos Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
Trademark Events
| Event Date | Event Description |
| Wednesday, February 14, 2024 | NEW APPLICATION ENTERED |
| Sunday, June 16, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 6, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, September 6, 2024 | ASSIGNED TO EXAMINER |
| Friday, September 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, September 6, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 22, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, October 22, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 22, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, October 22, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
